The search for a potent DNA vaccine against AIDS: the enhancement of immunogenicity by chemical and genetic adjuvants
- PMID: 9854503
The search for a potent DNA vaccine against AIDS: the enhancement of immunogenicity by chemical and genetic adjuvants
Abstract
DNA vaccination is a new way to generate antigen specific immune responses by inoculating plasmid DNA encoding microbial genes. We believe that the use of immunologic adjuvants together with DNA vaccines is a promising way to enhance and optimize DNA-derived immunity. Various chemical and genetic adjuvants have been explored in our recent study. Data from these studies suggests that adjuvants exert their immunomodulatory properties through several mechanisms such as lymphoid cells recruitment, cytokine induction, and the facilitation of DNA entry into cells. Furthermore, each adjuvant has unique immunomodulatory effects on cell-mediated and humoral immune responses induced by DNA vaccination to human immunodeficiency virus type 1. To optimize the desirable immune response, the choice of adjuvant and decision of immunization route are important considerations. A similar approach may be useful potentiating anticancer immunotherapy as well.
Similar articles
-
Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.Vaccine. 2007 Mar 1;25(11):2145-54. doi: 10.1016/j.vaccine.2006.10.057. Epub 2006 Nov 13. Vaccine. 2007. PMID: 17254672
-
Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants.Immunol Rev. 2004 Jun;199:84-99. doi: 10.1111/j.0105-2896.2004.00150.x. Immunol Rev. 2004. PMID: 15233728 Review.
-
HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.J Virol Methods. 2007 Dec;146(1-2):266-73. doi: 10.1016/j.jviromet.2007.07.016. Epub 2007 Sep 14. J Virol Methods. 2007. PMID: 17868910
-
Enhancing immune responses against HIV-1 DNA vaccine by coinoculating IL-6 expression vector.J Virol Methods. 2006 Sep;136(1-2):1-7. doi: 10.1016/j.jviromet.2006.01.020. Epub 2006 Jun 21. J Virol Methods. 2006. PMID: 16793146
-
New gene-based approaches for an AIDS vaccine.Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):357-72. doi: 10.1016/S0147-9571(03)00020-1. Comp Immunol Microbiol Infect Dis. 2003. PMID: 12818622 Review.
Cited by
-
Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models.Viruses. 2022 Feb 22;14(3):449. doi: 10.3390/v14030449. Viruses. 2022. PMID: 35336856 Free PMC article.
-
Expression library immunization: a road map for discovery of vaccines against infectious diseases.Infect Immun. 2005 Nov;73(11):7089-98. doi: 10.1128/IAI.73.11.7089-7098.2005. Infect Immun. 2005. PMID: 16239502 Free PMC article. Review. No abstract available.
-
DNA immunization as an efficient strategy for vaccination.Avicenna J Med Biotechnol. 2009 Jul;1(2):71-88. Avicenna J Med Biotechnol. 2009. PMID: 23407787 Free PMC article.
-
Vaccine development against HIV-1: current perspectives and future directions.Immunol Res. 2002;25(1):53-74. doi: 10.1385/ir:25:1:53. Immunol Res. 2002. PMID: 11868934 Review.
-
Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection.Drugs. 2000 Aug;60(2):481-516. doi: 10.2165/00003495-200060020-00016. Drugs. 2000. PMID: 10983742 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical